Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder
- PMID: 15939841
- DOI: 10.1001/archpsyc.62.6.642
Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder
Abstract
Context: Family and twin data suggest that, in addition to susceptibility genes specific for bipolar disorder or schizophrenia, genes exist that contribute to susceptibility across the traditional kraepelinian divide. Several studies have provided evidence that variation at the neuregulin 1 (NRG1) gene on chromosome 8p12 influences susceptibility to schizophrenia. The most consistent finding has been that one particular haplotype (the "core" haplotype) is overrepresented in cases compared with control subjects.
Objective: To investigate the possible role of NRG1 in bipolar disorder.
Design: Genetic case-control association analysis.
Setting: Subjects were unrelated and ascertained from general psychiatric inpatient and outpatient services.
Participants: Five hundred twenty-nine patients with DSM-IV bipolar I disorder and 1011 controls from the United Kingdom (100% white).
Methods: We genotyped the markers constituting the NRG1 core haplotype in cases and controls and reanalyzed our existing data from 573 DSM-IV schizophrenia cases with this larger set of controls.
Results: We found a significant difference in haplotype distribution between bipolar cases and controls globally (P = .003) and specifically for the core haplotype. Frequencies were 10.2% for bipolar cases and 7.8% for controls (effect size, as measured by odds ratio [OR], 1.37; 95% confidence interval [CI], 1.03-1.80; P = .04). The effect size in our bipolar sample was similar to that in our schizophrenia sample (OR, 1.22; 95% CI, 0.92-1.61). In the bipolar cases with predominantly mood-incongruent psychotic features (n = 193), the effect was greater (OR, 1.71; 95% CI, 1.29-2.59; P = .009), as was the case in the subset of schizophrenia cases (n = 27) who had experienced mania (OR, 1.64; 95% CI, 0.54-5.01).
Conclusions: Our findings suggest that neuregulin 1 plays a role in influencing susceptibility to bipolar disorder and schizophrenia and that it may exert a specific effect in the subset of functional psychosis that has manic and mood-incongruent psychotic features.
Similar articles
-
Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).Arch Gen Psychiatry. 2004 Apr;61(4):336-44. doi: 10.1001/archpsyc.61.4.336. Arch Gen Psychiatry. 2004. PMID: 15066891
-
Neuregulin-1 haplotype HAP(ICE) is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members.J Psychiatr Res. 2008 Nov;43(1):1-6. doi: 10.1016/j.jpsychires.2008.01.009. Epub 2008 Mar 4. J Psychiatr Res. 2008. PMID: 18291420
-
Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia.Mol Psychiatry. 2003 May;8(5):485-7. doi: 10.1038/sj.mp.4001348. Mol Psychiatry. 2003. PMID: 12808428
-
Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology.Biol Psychiatry. 2006 Jul 15;60(2):132-40. doi: 10.1016/j.biopsych.2005.11.002. Epub 2006 Jan 25. Biol Psychiatry. 2006. PMID: 16442083 Review.
-
The G72/G30 gene locus in psychiatric disorders: a challenge to diagnostic boundaries?Schizophr Bull. 2006 Oct;32(4):599-608. doi: 10.1093/schbul/sbl028. Epub 2006 Aug 16. Schizophr Bull. 2006. PMID: 16914640 Free PMC article. Review.
Cited by
-
Effect of the G72 (DAOA) putative risk haplotype on cognitive functions in healthy subjects.BMC Psychiatry. 2009 Sep 24;9:60. doi: 10.1186/1471-244X-9-60. BMC Psychiatry. 2009. PMID: 19778423 Free PMC article.
-
Hypothesis: grandiosity and guilt cause paranoia; paranoid schizophrenia is a psychotic mood disorder; a review.Schizophr Bull. 2008 Nov;34(6):1151-62. doi: 10.1093/schbul/sbm132. Epub 2007 Dec 1. Schizophr Bull. 2008. PMID: 18056109 Free PMC article. Review.
-
The effect of deficient muscarinic signaling on commonly reported biochemical effects in schizophrenia and convergence with genetic susceptibility loci in explaining symptom dimensions of psychosis.Front Pharmacol. 2014 Dec 15;5:277. doi: 10.3389/fphar.2014.00277. eCollection 2014. Front Pharmacol. 2014. PMID: 25566074 Free PMC article.
-
[Deconstructing schizophrenia. Dimensional models or division into subtypes?].Nervenarzt. 2012 Mar;83(3):345-54. doi: 10.1007/s00115-011-3255-1. Nervenarzt. 2012. PMID: 21424413 Review. German.
-
Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.Neuron. 2014 Jul 2;83(1):27-49. doi: 10.1016/j.neuron.2014.06.007. Neuron. 2014. PMID: 24991953 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical